Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese

Genes and Immunity

Volumn 7, Issue 1, 2006, Pages 81-84

  Tsuchiya, N ^a   Kobayashi, S ^b   Hashimoto, H ^b   Ozaki, S ^c   Tokunaga, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antineutrophil cytoplasmic antibody (ANCA); HLA; Japanese; Microscopic polyangiitis; Vasculitis

Indexed keywords

HLA DQA1 ANTIGEN; HLA DR ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; JAPAN; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; PROTEIN TARGETING;

ALLELES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; VASCULITIS;

EID: 33645164263     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364262     Document Type: Article

References (17)

1. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitis. Am J Med 2004; 117: 39-50.
2. Watts RA, Scott DGI. Epidemiology of the vasculitides. Curr Opin Rheumatol 2003; 15: 11-16.
3. Csernok E, Trabandt A, Gross WL. Immunogenetic aspects of ANCA-associated vasculitides. Exp Clin Immunogenet 1997; 14: 177-182.
4. Spencer SJ, Burns A, Gaskin G, Pusey CD, Rees AJ. HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int 1992; 41: 1059-1063.
5. Gencik M, Borgmann S, Zahn R, Albert E, Sitter T, Epplen JT et al. Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 1999; 117: 412-417.
6. Fujii A, Tomizawa K, Arimura Y, Nagasawa T, Ohashi YY, Hiyama T et al. Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis. Clin Nephrol 2000; 53: 242-252.
7. Tse WY, Abadeh S, Jefferis R, Savage CO, Adu D. Neutrophil FcγRIIIb allelic polymorphism in anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis. Clin Exp Immunol 2000; 119: 574-577.
8. Gencik M, Meller S, Borgmann S, Sitter T, Menezes Saecker AM, Fricke H et al. The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides. Clin Immunol 2000; 94: 9-12.
9. Meller S, Jagiello P, Borgmann S, Fricke H, Epplen JT, Gencik M. Novel SNPs in the CD18 gene validate the association with MPO-ANCA+ vasculitis. Genes Immun 2001; 2: 269-272.
10. Reynolds WF, Stegeman CA, Tervaert JW. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis. Clin Immunol 2002; 103: 154-160.
11. Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalence of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: A capture-recapture estimate. Arthritis Rheum 2004; 51: 92-99.
12. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register. Arthritis Rheum 2005; 53: 93-99.
13. Matsumoto Y, Nakayama T, Tamakoshi A, Ohno Y, Inaba Y, Kobayashi S et al. Nationwide epidemiological survey of refractory vasculitis (anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, anti-phospholipid syndrome and temporal arteritis) in Japan. 1998 Annual Report of the Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan 1999, pp 15-23. (in Japanese, abstract in English).
14. Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M et al. Genetic background of Japanese patients with ANCA-associated vasculitis: Association of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol 2003; 30: 1534-1540.
15. Tokunaga K, Ishikawa Y, Ogawa A, Wang H, Mitsunaga S, Moriyama S et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997; 46: 199-205.
16. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference, vol. 1, Oxford University Press: Oxford, 1992, pp 1065-1220.
17. Matsushita M, Tsuchiya N, Nakayama T, Ohashi J, Shibue T, Shiota M et al. Allele typing of human TNFA 5′-flanking region using PCR-PHFA (preferential homoduplex formation assay): Linkage disequilibrium with HLA class I and class II in Japanese. Tissue Antigens 1999; 54: 478-484.